L
Liberate Medical
Treating and diagnosing respiratory disease through non-invasive medical devices
About Liberate Medical
Liberate Medical is a healthcare technology company focused on developing innovative solutions to improve patient outcomes in critical care settings. The company's flagship product, the VentFree Respiratory Muscle Stimulator, is designed to reduce disuse atrophy of the abdominal wall muscles in mechanically ventilated patients. This device has received emergency use authorization in the USA, particularly for patients with COVID-19, and is CE marked for sale in the European Economic Area. By reducing the duration of mechanical ventilation and ICU stays, VentFree aims to decrease morbidity, mortality, and post-discharge complications, ultimately leading to significant cost savings for healthcare providers. The business primarily serves hospitals and intensive care units, operating within the critical care medical device market. Liberate Medical generates revenue through the sale of its VentFree device and related services.
Source: Dealroom company dataNews
Open roles
Liberate Medical in the Crestwood ecosystem
The Liberate Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
MedTech Innovator
US National Science Foundation
XLerateHealth
US Department of War
Series A1 investor entered at this stage
Scientific Health Development Partners
Source: Dealroom Talent Intelligence.
See Liberate Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

